GE HealthCare Receives FDA Clearance for Portrait VSM, Building on Its Growing Ecosystem of Connected Patient Monitoring Solutions
May 01, 2024
May 01, 2024
CHICAGO, Illinois, May 1 -- GE HealthCare issued the following news release on April 29, 2024:
GE HealthCare (Nasdaq: GEHC) today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Portrait VSM vital signs monitor that can provide clinicians with an accurate view of patient vital signs to support timely clinical decisions. As the next evolution of the DINAMAP legacy, Portrait VSM utilizes the SuperSTAT non-invasive blood pres . . .
GE HealthCare (Nasdaq: GEHC) today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Portrait VSM vital signs monitor that can provide clinicians with an accurate view of patient vital signs to support timely clinical decisions. As the next evolution of the DINAMAP legacy, Portrait VSM utilizes the SuperSTAT non-invasive blood pres . . .